Is EUDA Health Holdings Limited (EUDAW) overvalued? · rev $9.8M
EUDA Health Holdings Limited (EUDAW) common stock listed on US.
This page asks whether EUDA Health Holdings Limited (EUDAW) looks expensive on cached numbers — not a short thesis.
Latest reported EUDAW revenue for 2022-12-31 was $9.8M. Net income was -$24.9M. Revenue was down 6.7% from 2021-12-31 to 2022-12-31. EUDAW currently screens at market cap $0.
EUDAW currently screens at market cap $0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next EUDAW 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the EUDAW stock page for the full model, not this heading.
Not investment advice.